4015 Share Price Performance
ر.س140.50
-20.90 (-12.95%)
14.5% undervalued intrinsic discount
ر.س164.24
Fair Value
Price ر.س140.50
AnalystConsensusTarget ر.س164.24
Fair Valueر.س164.24
Share Pricen/a
Jamjoom Pharmaceuticals Factory Company Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
4015 Community Narratives
AN
Fair Value
·Fair Value ر.س164.24 14.5% undervalued intrinsic discount
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
Rising MENA Demand And Vision 2030 Investments Will Redefine Markets
Jamjoom Pharmaceuticals is betting on rising healthcare demand across the Middle East and North Africa, helped by Saudi healthcare spending and a push into new types of medicines beyond its traditional strengths. But its growth may come with trade-offs, like heavier exposure to lower-profit sales channels, reliance on partners for new products, and regional and supply constraints that could squeeze results.Read more
AN
ر.س164.24
14.5% undervalued intrinsic discount
Fair Value
Revenue
12.05% p.a.
Profit Margin
30.81%
Future PE
29.42x
Price in 2029
ر.س277.74
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
4015: Fair Value View Will Rely On Margins And Extraordinary Meeting Outcomes
Fair Value: ر.س164.24 14.5% undervalued intrinsic discount
11 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Jamjoom Pharmaceuticals Factory Company Key Details
About 4015
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Jamjoom Pharmaceuticals Factory Company, together with its subsidiaries, engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally. It provides human medicines; nutraceuticals; antibiotics; general analgesics; medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, and ulcer and acidity; treatment of various skin infections and cancer diseases; and eye drops, and ointments and cosmeceuticals. The company also offers ophthalmic solutions, dermatology products, cardiovascular health, consumer health, respiratory health, gastrointestinal health, endocrinology and diabetes care, central nervous system, and pain and inflammation pharmaceutical products. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
